Table 4.
HLA phenotype/serology | n (%) | p | pcorr | OR (95% CI) |
DRB1*03 | ||||
Synthetase | 44 (84.6) | 1 × 10-15 | 1 × 10-14 | 14.1 (6.3–35.2) |
PM-Scl | 11 (100) | 3 × 10-6 | 4 × 10-5 | 30.6 (4.4–1309.1) |
DRB1*07 | ||||
Mi-2 | 14 (77.8) | 4 × 10-6 | 5 × 10-5 | 11.1 (3.4–46.8) |
DQA1*02 | ||||
Mi-2 | 14 (77.8) | 9 × 10-6 | 5 × 10-5 | 11.6 (3.3–50.6) |
DQA1*05 | ||||
Synthetase | 42 (85.7) | 7 × 10-9 | 4 × 10-8 | 9.5 (3.8–26.5) |
PM-Scl | 11 (100) | 0.0002 | 0.001 | 18.9 (2.6–814.9) |
DQB1*02 | ||||
Synthetase | 42 (85.7) | 6.6 × 10-9 | 4 × 10-8 | 9.5 (3.8–26.5) |
Mi-2 | 15 (83.3) | 7 × 10-4 | 0.004 | 7.5 (2.0–41.9) |
PM-Scl | 11 (100) | 0.0003 | 0.001 | 18.0 (2.5–777.4) |
aResults are versus controls. CI, confidence interval; OR, odds ratio; p, probability; pcorr, corrected probability.